MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call
31 Julho 2023 - 6:35PM
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company
focused on developing, manufacturing and commercializing innovative
monoclonal antibody-based therapeutics for the treatment of cancer,
today announced that the Company will release its financial results
for the second quarter of 2023 after the market closes on
Wednesday, August 9, 2023. MacroGenics will host a conference call
to discuss the financial results and recent corporate progress on
Wednesday, August 9, 2023, at 4:30 pm ET.
Conference Call Information
To participate via telephone, please register in advance via
this link. Upon registration, all telephone participants will
receive a confirmation email detailing how to join the conference
call, including the dial-in number along with a unique passcode and
registrant ID that can be used to access the call. The listen-only
webcast of the conference call can be accessed under "Events &
Presentations" in the Investor Relations section of the Company's
website at http://ir.macrogenics.com/events.cfm. A recorded replay
of the webcast will be available shortly after the conclusion of
the call and archived on the Company's website for 30 days
following the call.
About MacroGenics, Inc.
MacroGenics is a biopharmaceutical company focused on
developing, manufacturing and commercializing innovative monoclonal
antibody-based therapeutics for the treatment of cancer. The
Company generates its pipeline of product candidates primarily from
its proprietary suite of next-generation antibody-based technology
platforms, which have applicability across broad therapeutic
domains. The combination of MacroGenics' technology platforms and
protein engineering expertise has allowed the Company to generate
promising product candidates and enter into several strategic
collaborations with global pharmaceutical and biotechnology
companies. For more information, please see the Company's website
at www.macrogenics.com. MacroGenics and the MacroGenics logo are
trademarks or registered trademarks of MacroGenics, Inc.
###
CONTACTS:
Jim Karrels, Senior Vice President, CFO
1-301-251-5172, info@macrogenics.com
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
MacroGenics (NASDAQ:MGNX)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024